FindTrial
Sign In

To evaluate the efficacy of Menâ??s Under Eye Serum in reducing the under eye dark circles, puffiness and wrinkles on healthy human male volunteers.

Efficacy evaluation of Menâ??s Under Eye Serum on healthy human male volunteers.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2012/12/003189
Enrollment
35
Registered
2012-12-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: UES-M: Baseline (week 0), week 1 to week 8 assessment of dermatologist, instrument and subject Control Intervention1: Baseline readings: Baseline (week 0), week 1 to week 8

Sponsors

ITC RD CENTRE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Male subjects in generally good health. 2. Subjects in the age group of 25 to 65 years. 3. 17-18 subjects with moderate to severe under eye dark circles, 17-18 Subjects with puffiness, 17-18 Subjects with moderate to severe fine lines and wrinkles in addition to either of the above mentioned conditions. 4. Subjects free of any obvious infection of skin as determined by dermatologist. 5. Subject has not participated in a similar investigation in the past four weeks. 6. Subjects have not used a similar product for the last four weeks. 7. Subjects willing to give a written informed consent and come for regular follow up.

Exclusion criteria

Exclusion criteria: 1. Subjects with known allergies or sensitivities to cosmetic products, toiletries or its components like fragrances, preservatives, hydroquinone, vitamin C, Niacin amide, retinol, soy etc. 2. Currently or has been using a similar type of product within the last 1 month. 3. Currently or has been undergoing dermatologist skin treatments or procedures within the last 1 month. 4. Currently or has been involved in another skin care clinical investigation within the last 1 months. 5. Subjects who have pre-existing or dormant dermatologic conditions (e.g., psoriasis, rosacea, rashes, eczema, many and/or severe excoriations etc.) that could interfere with the outcome of the study as determined by the investigator. 6. Subjects viewed by the investigator as not being able to complete the study.

Design outcomes

Primary

MeasureTime frame
To test the efficacy of investigational formulations in reducing under eye dark circles and puffinessTimepoint: Baseline (week 0), week 1 to week 8—

Secondary

MeasureTime frame
To test the efficacy of investigational formulations in reducing under eye fine lines and wrinkles.Timepoint: Baseline (week 0), week 1 to week 8—

Countries

India

Contacts

Public ContactMeghana Surve
meghana@kelkarcosmetology.com25639644

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026